文献速递心力衰竭与心肌病血脂与心血管预防

社区成人糖尿病合并心肌病的患病率与预后意义

Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

该研究汇总3个队列中无心血管病或心衰的成人,在2900例糖尿病患者中评估糖尿病合并心肌病(DbCM)的患病率与心衰风险。DbCM患病率随定义严格程度从67.0%降至11.7%,5年心衰发生率8.4%–12.8%。相比血糖正常者,DbCM显著增加新发心衰风险,最严格定义风险最高(HR 2.55)。

要点

  • DbCM患病率因定义不同差异大,最宽松67.0%、最严格11.7%。
  • DbCM患者5年心衰发生率8.4%–12.8%,风险显著高于血糖正常者。
  • 最严格定义DbCM的心衰风险最高(HR 2.55,95%CI 1.69–3.86)。

核心结论

  • 无论采用何种心肌病定义,DbCM均识别出心衰高危亚组。

研究设计与样本

  • 汇总ARIC、CHS、CRIC三个队列中无心血管病或心衰的成人,共10208例,其中糖尿病患者2900例。
  • DbCM采用三种定义:最宽松为≥1项超声心动图异常,中间为≥2项异常,最严格为NT-proBNP升高加≥2项异常。
  • 采用调整Fine-Gray模型评估心衰风险。

主要发现

  • 糖尿病患者中DbCM患病率从最宽松定义的67.0%到最严格定义的11.7%。
  • DbCM患者5年心衰发生率从最宽松定义的8.4%到最严格定义的12.8%。
  • 相比血糖正常者,最严格定义DbCM的新发心衰风险HR为2.55(95%CI 1.69–3.86),最宽松定义HR为1.99(95%CI 1.50–2.65)。
  • 较高空腹血糖、体重指数、年龄及较差肾功能与DbCM风险升高相关。
  • 结果在各队列、性别和种族亚组及无高血压或肥胖者中一致。

关键数值与推荐

  • 最宽松定义:≥1项超声心动图异常(左房扩大、左室肥厚、舒张功能障碍)。
  • 中间定义:≥2项超声心动图异常。
  • 最严格定义:NT-proBNP升高(正常/超重者>125 pg/mL,肥胖者>100 pg/mL)加≥2项超声心动图异常。

临床怎么用

  • 对糖尿病患者应关注DbCM,尤其结合超声心动图和NT-proBNP识别心衰高危者。
  • 采用更严格定义可识别心衰风险更高的亚组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes is associated with abnormalities in cardiac remodeling and high risk of heart failure (HF). OBJECTIVES: The purpose of this study was to evaluate the prevalence and prognostic implications of diabetes with cardiomyopathy (DbCM) among community-dwelling individuals. METHODS: Adults without prevalent cardiovascular disease or HF were pooled from 3 cohort studies (ARIC [Atherosclerosis Risk In Communities], CHS [Cardiovascular Health Study], CRIC [Chronic Renal Insufficiency Cohort]). Among participants with diabetes, DbCM was defined using different definitions: 1) least restrictive: ≥1 echocardiographic abnormality (left atrial enlargement, left ventricle hypertrophy, diastolic dysfunction); 2) intermediate restrictive: ≥2 echocardiographic abnormalities; and 3) most restrictive: elevated N-terminal pro-B-type natriuretic peptide levels (>125 in normal/overweight or >100 pg/mL in obese) plus ≥2 echocardiographic abnormalities. Adjusted Fine-Gray models were used to evaluate the risk of HF. RESULTS: Among individuals with diabetes (2,900 of 10,208 included), the prevalence of DbCM ranged from 67.0% to 11.7% in the least and most restrictive criteria, respectively. Higher fasting glucose, body mass index, and age as well as worse kidney function were associated with higher risk of DbCM. The 5-year incidence of HF among participants with DbCM ranged from 8.4%-12.8% in the least and most restrictive definitions, respectively. Compared with euglycemia, DbCM was significantly associated with higher risk of incident HF with the highest risk observed for the most restrictive definition of DbCM (HR: 2.55 [95% CI: 1.69-3.86]; least restrictive criteria HR: 1.99 [95% CI: 1.50-2.65]). A similar pattern of results was observed across cohort studies, across sex and race subgroups, and among participants without hypertension or obesity. CONCLUSIONS: Regardless of the criteria used to define cardiomyopathy, DbCM identifies a high-risk subgroup for developing HF.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Segar MW, Khan MS, Patel KV, et al. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults. J Am Coll Cardiol. 2021. PMID: 34649696. doi:10.1016/j.jacc.2021.08.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。